159 related articles for article (PubMed ID: 1540960)
1. DNA damage and cytotoxicity in L1210 cells by ellipticine and a structural analogue, N-2-(diethylaminoethyl)-9-hydroxyellipticinium chloride.
Djuric Z; Everett CK; Valeriote FA
Cancer Res; 1992 Mar; 52(6):1515-9. PubMed ID: 1540960
[TBL] [Abstract][Full Text] [Related]
2. 8-methoxycaffeine-induced protein-associated DNA breaks in isolated L1210 cell nuclei.
Zignaigo G; Vigani A; Billi G; Brega I; Piccini D; Poggi L; Parodi S; Russo P
Boll Soc Ital Biol Sper; 1990 Jun; 66(6):587-94. PubMed ID: 2175203
[TBL] [Abstract][Full Text] [Related]
3. Topoisomerase II-mediated DNA damage produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and related acridines in L1210 cells and isolated nuclei: relation to cytotoxicity.
Covey JM; Kohn KW; Kerrigan D; Tilchen EJ; Pommier Y
Cancer Res; 1988 Feb; 48(4):860-5. PubMed ID: 2827887
[TBL] [Abstract][Full Text] [Related]
4. Production of protein-associated DNA breaks by 10-[diethylaminopropylamino]-6-methyl-5H-pyrido[3',4':4,5]pyrrolo [2,3-g]isoquinoline in cultured L1210 cells and in isolated nuclei: comparison with other topoisomerase II inhibitors.
Pierson V; Pierre A; Pommier Y; Gros P
Cancer Res; 1988 Mar; 48(6):1404-9. PubMed ID: 2830964
[TBL] [Abstract][Full Text] [Related]
5. In vivo DNA cross-linking by cyclophosphamide: comparison of human chronic lymphatic leukemia cells with mouse L1210 leukemia and normal bone marrow cells.
DeNeve W; Valeriote F; Edelstein M; Everett C; Bischoff M
Cancer Res; 1989 Jul; 49(13):3452-6. PubMed ID: 2731167
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro.
Bowman KJ; Newell DR; Calvert AH; Curtin NJ
Br J Cancer; 2001 Jan; 84(1):106-12. PubMed ID: 11139322
[TBL] [Abstract][Full Text] [Related]
7. Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells.
Mattern MR; Mong SM; Bartus HF; Mirabelli CK; Crooke ST; Johnson RK
Cancer Res; 1987 Apr; 47(7):1793-8. PubMed ID: 3028614
[TBL] [Abstract][Full Text] [Related]
8. Effects of the bifunctional antitumor intercalator ditercalinium on DNA in mouse leukemia L1210 cells and DNA topoisomerase II.
Markovits J; Pommier Y; Mattern MR; Esnault C; Roques BP; Le Pecq JB; Kohn KW
Cancer Res; 1986 Nov; 46(11):5821-6. PubMed ID: 3019538
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity and DNA damage caused by the azoxy metabolites of procarbazine in L1210 tumor cells.
Erikson JM; Tweedie DJ; Ducore JM; Prough RA
Cancer Res; 1989 Jan; 49(1):127-33. PubMed ID: 2908840
[TBL] [Abstract][Full Text] [Related]
10. Repair of deoxyribonucleic acid lesions caused by adriamycin and ellipticine.
Ross WE; Smith MC
Biochem Pharmacol; 1982 May; 31(10):1931-5. PubMed ID: 7104026
[TBL] [Abstract][Full Text] [Related]
11. Dual topoisomerase I and II inhibition by intoplicine (RP-60475), a new antitumor agent in early clinical trials.
Poddevin B; Riou JF; Lavelle F; Pommier Y
Mol Pharmacol; 1993 Oct; 44(4):767-74. PubMed ID: 8232227
[TBL] [Abstract][Full Text] [Related]
12. Interaction of N,N',N''-triethylenethiophosphoramide and N,N',N''-triethylenephosphoramide with cellular DNA.
Cohen NA; Egorin MJ; Snyder SW; Ashar B; Wietharn BE; Pan SS; Ross DD; Hilton J
Cancer Res; 1991 Aug; 51(16):4360-6. PubMed ID: 1714342
[TBL] [Abstract][Full Text] [Related]
13. DNA damage as a basis for 4'-demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-D-glucopyranoside) (etoposide) cytotoxicity.
Wozniak AJ; Ross WE
Cancer Res; 1983 Jan; 43(1):120-4. PubMed ID: 6847761
[TBL] [Abstract][Full Text] [Related]
14. Production of protein-associated DNA breaks by 8-methoxycaffeine, caffeine and 8-chlorocaffeine in isolated nuclei from L1210 cells: comparison with those produced by topoisomerase II inhibitors.
Russo P; Poggi L; Parodi S; Pedrini AM; Kohn KW; Pommier Y
Carcinogenesis; 1991 Oct; 12(10):1781-90. PubMed ID: 1657426
[TBL] [Abstract][Full Text] [Related]
15. DNA double-stranded breaks in mammalian cells after exposure to intercalating agents.
Ross WE; Bradley MO
Biochim Biophys Acta; 1981 Jun; 654(1):129-34. PubMed ID: 7272306
[TBL] [Abstract][Full Text] [Related]
16. DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues.
Hsiang YH; Liu LF; Wall ME; Wani MC; Nicholas AW; Manikumar G; Kirschenbaum S; Silber R; Potmesil M
Cancer Res; 1989 Aug; 49(16):4385-9. PubMed ID: 2545341
[TBL] [Abstract][Full Text] [Related]
17. Topoisomerase II-mediated DNA breaks and cytotoxicity in relation to cell proliferation and the cell cycle in NIH 3T3 fibroblasts and L1210 leukemia cells.
Markovits J; Pommier Y; Kerrigan D; Covey JM; Tilchen EJ; Kohn KW
Cancer Res; 1987 Apr; 47(8):2050-5. PubMed ID: 3030540
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl.
Auclair C; Pierre A; Voisin E; Pepin O; Cros S; Colas C; Saucier JM; Verschuere B; Gros P; Paoletti C
Cancer Res; 1987 Dec; 47(23):6254-61. PubMed ID: 3677074
[TBL] [Abstract][Full Text] [Related]
19. Quinone-induced DNA damage and its relationship to antitumor activity in L5178Y lymphoblasts.
Begleiter A; Blair GW
Cancer Res; 1984 Jan; 44(1):78-82. PubMed ID: 6537800
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of topoisomerase II-mediated DNA cleavage by ellipticine derivatives: structure-activity relationship.
Fossé P; René B; Charra M; Paoletti C; Saucier JM
Mol Pharmacol; 1992 Oct; 42(4):590-5. PubMed ID: 1331751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
